# FDA 483 - Naturavit Inc - April 07, 2022

Source: https://www.keypedia.com/records/483/naturavit-inc/05861494-4741-439f-8f21-3603dd343a02

> FDA 483 for Naturavit Inc on April 07, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Naturavit Inc
- Inspection Date: 2022-04-07
- Product Type: drugs
- Office Name: Office of Medical Device and Radiological Health Division II
- Summary: An FDA inspection of Naturavit Inc, a dietary supplements own label distributor in Miami, FL, revealed significant deficiencies in their manufacturing and quality control processes. The firm failed to establish product specifications for finished dietary supplements, did not ensure components met specifications through testing or certificates of analysis, and did not follow its own written procedures for vendor qualification and labeling operations. Several of these issues were repeat observations from previous FDA inspections, indicating a persistent lack of compliance.

## Related Documents

- [483 - 2025-01-14](https://www.keypedia.com/records/483/naturavit-inc/d9e643fe-57d9-41b4-906a-ac8c36896130)

## Related Officers

- [Benita C. Okeke](https://www.keypedia.com/people/benita-c-okeke/1c62b9fb-4cc6-4d6b-966c-98b471d850e4)
- [investigator](https://www.keypedia.com/people/marinee-flores-marrero/60e1fba5-b832-4111-a500-3cf952a349fb)

Company: https://www.keypedia.com/companies/naturavit-inc/d6a84537-0f94-4ebe-82f1-05e1729d4de0

Office: https://www.keypedia.com/offices/office-of-medical-device-and-radiological-health-division-ii/ae9bd439-479a-420d-9dd8-9fe1fc0863d6